BioLargo Discusses PFAS Commercialization, Garratt-Callahan Partnership, and $1.2 Million in New Engineering Contracts with The Stock Day Podcast
1 tracks • 0 plays • 0 favorites
BioLargo Discusses PFAS Commercialization, Garratt-Callahan Partnership, and $1.2 Million in New Engineering Contracts with The Stock Day Podcast
adilmrabbichow2
0:0013:27
Business & Finance
Episodes
1
BioLargo Discusses PFAS Commercialization, Garratt-Callahan Partnership, and $1.2 Million in New Engineering Contracts with The Stock Day Podcast
adilmrabbichow2